Single-Tablet Regimens for the Treatment of HIV-1 Infection.

Item

http://www.wikidata.org/entity/Q39022885

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Single-Tablet Regimens for the Treatment of HIV-1 Infection.

@en

Single-Tablet Regimens for the Treatment of HIV-1 Infection.

@nl

type

Item

label

Single-Tablet Regimens for the Treatment of HIV-1 Infection.

@en

Single-Tablet Regimens for the Treatment of HIV-1 Infection.

@nl

prefLabel

Single-Tablet Regimens for the Treatment of HIV-1 Infection.

@en

Single-Tablet Regimens for the Treatment of HIV-1 Infection.

@nl

P1476

Single-Tablet Regimens for the Treatment of HIV-1 Infection.

@en

P2093

Denise Kelley

http://www.w3.org/2001/XMLSchema#string

Jamielynn C Sebaaly

http://www.w3.org/2001/XMLSchema#string

P2860

Tenofovir alafenamide: A novel prodrug of tenofovir for the treatment of Human Immunodeficiency Virus

Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks

Dolutegravir in antiretroviral-experienced patients with raltegravir- and/or elvitegravir-resistant HIV-1: 24-week results of the phase III VIKING-3 study

Single-Tablet Regimens in HIV Therapy

No association of abacavir use with myocardial infarction: findings of an FDA meta-analysis.

Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study.

Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Patients With Renal Impairment: 48-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study

Dolutegravir.

Dolutegravir, a second-generation integrase inhibitor for the treatment of HIV-1 infection.

Single-pill combination regimens for treatment of HIV-1 infection.

P304

332-344

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1060028016682531

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27895236

http://www.w3.org/2001/XMLSchema#string